Corporate Foundations
12 impact funders on Causeartist list corporate foundations among their investment themes. This focus archive helps founders and LPs find aligned capital, compare mandates, and identify co-investors in corporate foundations.
Society for Science
FoundationSociety for Science is a 501(c)(3) non-profit organization dedicated to promoting science through comprehensive education programs, prestigious science competitions, and publications including Science News magazine and Science News Explores. The organization operates world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair, and the Thermo Fisher Scientific Junior Innovators Challenge, which nurture and celebrate young innovators tackling the world's most challenging problems.
Their mission centers on expanding scientific literacy, effective STEM education, and scientific research through informing, educating, and inspiring communities. The organization operates as a membership-based nonprofit focused on promoting understanding and appreciation of science and its vital role in human advancement. They provide various programs including STEM outreach, teacher conferences, research grants, and educational resources to support scientific learning at multiple levels.
Society for Science has been a champion for science education and research for more than 100 years, creating significant impact in the scientific ecosystem by identifying and supporting future scientific leaders. Their competitions and programs create lifelong connections that empower the next generation of scientists and researchers. The organization's sustained commitment to scientific advancement has helped shape the careers of countless young scientists who go on to make breakthrough discoveries and innovations.
EducationUnited States
T1D Fund
FoundationT1D Fund is the world's first scaled venture fund dedicated exclusively to type 1 diabetes, operating as an impact investment fund that supports promising companies through equity investments and expertise. They focus specifically on accelerating treatments, prevention, and cures for the approximately 9 million people living with T1D globally.
The fund operates as a powerful platform for collaboration, using catalytic capital and expertise to de-risk investments and create a flywheel effect that attracts other investors to the T1D space. As a wholly owned, not-for-profit independently run subsidiary of Breakthrough T1D, they leverage their intellectual capital and expert network to offer comprehensive support to portfolio companies, steering them through regulatory, clinical, and commercial milestones.
With over $200 million in assets under management and 25+ active portfolio companies, T1D Fund creates significant impact in the diabetes ecosystem by reinvesting 100% of returns to propel continuous progress. Their unique position as subject matter experts combined with access to Breakthrough T1D's extensive network of research, clinical, and medical expertise enables them to transform the landscape of T1D investment and accelerate the development of life-changing therapies.
Health & WellnessUnited States